To recognize her valuable contributions to the practice of pharmacy and future generations of pharmacists, Dr. Emily Hollinghurst (Class of 2012) was named Loma Linda University School of Pharmacy's 2025 Alum of the Year!
After graduating from LLUSP, Dr. Emily Hollinghurst completed her PGY1 Pharmacy Practice and PGY2 Oncology Pharmacy residencies at LLU Medical Center. Immediately after finishing residency in 2014, Dr. Hollinghurst worked as the adult inpatient oncology pharmacist at LLUMC where she participated in daily rounds and monitored and managed patients undergoing complex chemotherapy treatments. Dr. Hollinghurst worked briefly for Cigna’s PBM focusing in oncology therapeutics; however when there was an opening at LLU Specialty Pharmacy, Dr. Hollinghurst knew she wanted to return to working with patients and teaching students and residents. From 2019 to 2023, she served as a member of the specialty pharmacy team where she focused on oral oncolytics. Dr. Hollinghurst pioneered the specialty pharmacy residency program at LLUSP as well as developed the Medi-Cal MTM program within the pharmacy. During her tenure at LLUMC, she was a preceptor and mentor for several students and residents.
Dr. Hollinghurst has presented at CSHP Seminar and Asembia’s annual conference. She has served as a contributor to pharmacy CE programs accessible to pharmacists across the country. Dr. Hollinghurst holds an Advanced Practice Pharmacist license in California and has maintained her BCOP certification since 2016. Since July 2023, Dr. Hollinghurst has been a breast cancer medical science liaison within the US Oncology Medical Affairs division at AstraZeneca.
Besides her work as a pharmacist, Dr. Hollinghurst is a wife and mom of two beautiful children. In her free time, she enjoys gardening and running. In fact, the day after receiving her award at LLUSP's Homecoming dinner, she ran her second 10K of 2025 in the Run Through Redlands.